Article Text

Download PDFPDF
Can the published cost analysis data for delivery of an efficient primary angioplasty service be applied to the modern National Health Service?


Despite the clinical benefits and safety profile of primary percutaneous coronary intervention (PCI), the health care system in the UK has been slow to adopt this strategy as first line management for ST segment elevation myocardial infarction. The cost implications of a 24 hour a day, seven days per week primary PCI service and the absence of an existing efficient working model within the National Health Service (NHS) framework are two of the major deterrents for provision of such a service. The existent cost effectiveness data for primary PCI is critically reviewed, with particular reference to the NHS.

  • NHS, National Health Service
  • PCI, percutaneous coronary intervention
  • PAMI, primary angioplasty in myocardial infarction
  • POBA, plain old balloon angioplasty
  • rt-PA, recombinant tissue plasminogen activator
  • STEMI, ST elevation myocardial infarction
  • QALY, quality adjusted life-year
  • primary angioplasty
  • cost effectiveness
  • National Health Service
  • NHS

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.